Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Dermal papilla cells help wounds heal better and can potentially grow new hair.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

3D culture helps maintain hair growth cells better than 2D culture and identifies key genes for potential hair loss treatments.

Substance from human umbilical cord blood cells promotes hair growth.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Cell-based therapies using dermal papilla cells and adipocyte lineage cells show potential for hair regeneration.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Different substances affect hair and skin cell growth in various ways.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

ADSC-Exos with miR-122-5p can help treat hair loss by promoting hair growth.

TGF-β2 plays a key role in human hair growth and development.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

Garudan Kizhangu Ennai may effectively treat alopecia areata but needs more research to confirm its safety and effectiveness.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Stem cells from umbilical cords can help regrow hair in mice with hair loss.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

Cyclosporin doesn't stop hair loss.

Terbinafine can cause hair loss.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Intralesional triamcinolone is the most effective treatment for hair regrowth in alopecia areata patients.